Guillermo Elizondo-Riojas

Guillermo Elizondo-Riojas

Auto-generated profile, based on publicly available information

Guillermo Elizondo-Riojas

Department of Radiology, Centro Universitario de Imagen Diagnóstica, Hospital Universitario Dr. José Eleuterio González, Universidad Autónoma de Nuevo León, Av Gonzalitos y Madero, San Nicolás de los Garza, Monterrey 66451, Nuevo León, Mexico

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 September 2021 in International Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
LFLucía T. Fernández
Lucía T. Fernández
Sonia Sofía Ocampo-GarzaSonia Sofía Ocampo-Garza
Sonia Sofía Ocampo-Garza
GEGuillermo Elizondo‐Riojas
Guillermo Elizondo‐Riojas
JOJorge Ocampo‐Candiani
Jorge Ocampo‐Candiani

29 June 2017 in American Journal of Neuroradiology
Verified
Journal Article
Open access
PDF file
KMK.R. Maravilla
K.R. Maravilla
DODANIEL San Juan Orta
DANIEL San Juan Orta
SKS.J. Kim
S.J. Kim
GEG. Elizondo-Riojas
G. Elizondo-Riojas
JFJ.R. Fink
J.R. Fink
JFJ.B. Fiebach
J.B. Fiebach
BACKGROUND AND PURPOSE: Effective management of patients with brain tumors depends on accurate detection and characterization of lesions. This study aimed to demonstrate the noninferiority of gadoterate meglumine versus gadobutrol for overall visualization and characterization of primary brain tumors. MATERIALS AND METHODS: This multicenter, double-blind, randomized, controlled intraindividual, crossover, noninferiority study included 279 patients. Both contrast agents (dose = 0.1 mmol/kg of body weight) were assessed with 2 identical MRIs at a time interval of 2–14 days. The primary end point was overall lesion visualization and characterization, scored independently by 3 off-site readers on a 4-point scale, ranging from “poor” to “excellent.” Secondary end points were qualitative assessments (lesion border delineation, internal morphology, degree of contrast enhancement, diagnostic confidence), quantitative measurements (signal intensity), and safety (adverse events). All qualitative assessments were also performed on-site. RESULTS: For all 3 readers, images of most patients (>90%) were scored good or excellent for overall lesion visualization and characterization with either contrast agent; and the noninferiority of gadoterate meglumine versus gadobutrol was statistically demonstrated. No significant differences were observed between the 2 contrast agents regarding qualitative end points despite quantitative mean lesion percentage enhancement being higher with gadobutrol (P < .001). Diagnostic confidence was high/excellent for all readers in >81% of the patients with both contrast agents. Similar percentages of patients with adverse events related to the contrast agents were observed with gadoterate meglumine (7.8%) and gadobutrol (7.3%), mainly injection site pain. CONCLUSIONS: The noninferiority of gadoterate meglumine versus gadobutrol for overall visualization and characterization of primary brain tumors was demonstrated.

1 November 2020 in RadioGraphics
Verified
Journal Article
Closed access
CSClaudio F. Silva
Claudio F. Silva
GEGuillermo Elizondo-Rojas
Guillermo Elizondo-Rojas
OAOmolola Atalabi
Omolola Atalabi
MKMusturay Karçaaltincaba
Musturay Karçaaltincaba
GMGiovanni Morana
Giovanni Morana
OMOn Behalf Of The Cire Members
On Behalf Of The Cire Members
The 25-year history of the RSNA Committee on International Radiology Education and its varied global radiology programs is explored, as well as the committee’s newest initiative, the Global Learnin... The Radiological Society of North America (RSNA) Committee on International Radiology Education (CIRE) has worked for the past 25 years to create academic programs oriented to the needs of internat...

1 November 2020 in Journal of Vascular and Interventional Radiology
Verified
Journal Article
Closed access
GEGuillermo Elizondo
Guillermo Elizondo
MEMitchell Eggers
Mitchell Eggers
MFMario Falcon
Mario Falcon
MTMiguel Trevino
Miguel Trevino
RMRoberto Marrufo
Roberto Marrufo
JSJoseph Steele
Joseph Steele

31 August 2022 in Radiology: Artificial Intelligence
Verified
Journal Article
Closed access
FKFelipe Campos Kitamura
Felipe Campos Kitamura
FNFelipe Barjud Pereira Do Nascimento
Felipe Barjud Pereira Do Nascimento
GEGuillermo Elizondo-Riojas
Guillermo Elizondo-Riojas
HCHernán Chaves
Hernán Chaves
HLHéctor Henríquez Leighton
Héctor Henríquez Leighton
CNCésar Higa Nomura
César Higa Nomura
“Just Accepted” papers have undergone full peer review and have been accepted for publication in Radiology: Artificial Intelligence. This article will undergo copyediting, layout, and proof review ...

1 November 2021 in Journal of the American College of Surgeons
Verified
Journal Article
Closed access
PDF file
AQAlejandro Quiroga-Garza
Alejandro Quiroga-Garza
YHYenitzeh Ak. Hernández-Garate
Yenitzeh Ak. Hernández-Garate
RVRaul A. de Luna Vega
Raul A. de Luna Vega
BFBernardo Alfonso Fernandez-Rodarte
Bernardo Alfonso Fernandez-Rodarte
RPRicardo Pinales-Razo
Ricardo Pinales-Razo
SGSantos Guzman-Lopez
Santos Guzman-Lopez
The Trendelenburg position was originally described (1860) with the patient in supine decubitus with a head-down tilt of 45o below the breech plane to favor venous return by gravity, for central venous catheterization. This position is not viable or clinically practical. The objective was to determine the most comfortable angulation and the morphological changes of the right internal jugular vein (RIJV).